Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telomir Pharmaceuticals

4.25
+0.12623.06%
Volume:50.53K
Turnover:211.27K
Market Cap:126.38M
PE:-7.59
High:4.25
Open:4.20
Low:4.09
Close:4.12
Loading ...

Telomir Pharmaceuticals- Confirms Copper-Binding Capabilities of Telomir-1, Expands Pipeline Into Wilson's Disease

THOMSON REUTERS
·
23 Dec 2024

Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026

THOMSON REUTERS
·
23 Dec 2024

EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease

Benzinga
·
23 Dec 2024

Telomir Pharmaceuticals Shares Down 12.57% at $4.45 in Premarket Trade; White Diamind Research Says It Has a Strong Sell Rating on the Stock

THOMSON REUTERS
·
13 Dec 2024

Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price

ACCESSWIRE
·
12 Dec 2024

Closing Bell Movers: Adobe down over 8% on guidance shortfall

TIPRANKS
·
12 Dec 2024

Telomir Pharmaceuticals enters into stock purchase agreement for $1M

TIPRANKS
·
12 Dec 2024

Telomir Pharmaceuticals' Shares Rally After Positive Results for Diabetes Treatment

Dow Jones
·
04 Dec 2024

Telomir Pharmaceuticals announces preclinical results on Telomir-1

TIPRANKS
·
03 Dec 2024

Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1

ACCESSWIRE
·
03 Dec 2024

TELO Test Results Continue to Excite

Zacks Small Cap Research
·
03 Dec 2024

Telomir Pharmaceuticals: Reversal of Key Type 2 Diabetes Parameters in Preclinical Study With Telomir-1

THOMSON REUTERS
·
03 Dec 2024

Sector Update: Health Care Stocks Climb Thursday Afternoon

MT Newswires Live
·
22 Nov 2024

Telomir Pharmaceuticals Says Telomir-1 Preclinical Data Show Age Reversal; Shares Rise

MT Newswires Live
·
21 Nov 2024

Telomir Pharmaceuticals announces preclinical results on Telomir-1

TIPRANKS
·
21 Nov 2024

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1

ACCESSWIRE
·
21 Nov 2024